Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
39°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALY
Recent news which mentions ESALY
< Previous
1
2
3
4
5
Next >
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
Offerings
Market News
CEMI
From
Benzinga
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
February 25, 2022
Tickers
ESALF
ESALY
MRK
Tags
General
News
Benzinga
From
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Tickers
ALKS
AMGN
ARGX
BGNE
Tags
General
ALKS
OMER
From
Benzinga
Merck Snags Yet Another Indication for This Drug Combo
January 14, 2022
Tickers
ESALY
MRK
Tags
Market News
MRK
ESALY
From
Motley Fool
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Market News
Movers
RHHBF
From
Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
December 16, 2021
Tickers
BIIB
ESALF
ESALY
Tags
General
BIIB
Benzinga
From
Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
November 29, 2021
Tickers
ESALF
ESALY
MRK
Tags
Benzinga
Health Care
News
From
Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Biotech
Phase 3 Trial
From
Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
November 11, 2021
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Biotech
BIIB
From
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Tickers
APTO
APYX
BIIB
BLFS
Tags
PROG
BIIB
HGEN
From
Benzinga
3 Big Problems With Biogen's Q3 Results
October 23, 2021
Tickers
BIIB
ESALY
SAGE
Tags
Market News
SAGE
BIIB
From
Motley Fool
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
September 28, 2021
Tickers
BIIB
ESALF
ESALY
Tags
General
Benzinga
BIIB
From
Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Tickers
AFIB
ALT
AMZN
APYX
Tags
CRDL
INCY
EGRX
From
Benzinga
How Keytruda's Latest Approval in China Boosts Merck
September 11, 2021
Tickers
ESALY
MRK
Tags
ESALY
Market News
MRK
From
Motley Fool
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
September 10, 2021
Tickers
CTXR
ESALY
RDY
Tags
CTXR
pharmaceuticals
Biotech
From
Benzinga
Merck Investors Have Reason to Cheer This Label Expansion
September 09, 2021
Tickers
ESALY
MRK
Tags
Market News
MRK
ESALY
From
Motley Fool
Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma
September 07, 2021
Tickers
ESALF
ESALY
RDY
Tags
ESALY
oncology
Briefs
From
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Tickers
ABSI
AGEN
ALKS
AXNX
Tags
NVAX
VERV
Penny Stocks
From
Benzinga
Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free
August 30, 2021
Tickers
BIIB
ESALF
ESALY
Tags
ESALY
Briefs
Market News
From
Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
August 29, 2021
Tickers
ADGI
ASND
BNR
BNTX
Tags
RNXT
General
IBB
From
Benzinga
What This Label Expansion Means for Merck
August 22, 2021
Tickers
ESALY
MRK
PFE
Tags
MRK
PFE
Market News
From
Motley Fool
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
August 20, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
ESALY
Market News
From
Benzinga
Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei's
August 17, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
ESALF
ESALY
From
Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
Tickers
ABSI
AXSM
BIOC
BNTX
Tags
ELYM
News
PFE
From
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Tickers
ABCL
ACET
ACHV
ADGI
Tags
ETON
KNSA
HARP
From
Benzinga
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
August 12, 2021
Tickers
BIIB
ESALF
ESALY
Tags
General
BIIB
Benzinga
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
August 02, 2021
Tickers
ALBO
AXSM
CARA
CCXI
Tags
CARA
ESALY
Small Cap
From
Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Tickers
ABBV
ABSI
ACET
ALKS
Tags
TBIO
ABBV
Earnings
From
Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
July 27, 2021
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Biotech
Aduhelm
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Tickers
ABT
ARVN
AVTE
BHVN
Tags
PSTV
MDNA
CRTX
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.